Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia

Clinical trial NCT01260116 · UNKNOWN

Trial details

NCT number: NCT01260116
Sponsor: Wuhan University
Status: UNKNOWN
Study type: OBSERVATIONAL

The Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores.The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales.Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc.Subjective Well-being Under Neuroleptics Short Form Will be Used in Our Study to Assess the Subjective Side-effects.

Start date: 2010-12-01
Primary completion: 2011-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.